Clinical data | |
---|---|
Trade names | Claritin, Claratyne, Clarityn, others |
AHFS/Drugs.com | Monograph |
MedlinePlus | a697038 |
License data |
|
Pregnancy category |
|
Routes of administration | By mouth |
Drug class | Second-generation antihistamine |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | almost 100% |
Protein binding | 97–99% |
Metabolism | liver (CYP2D6- and 3A4-mediated) |
Elimination half-life | 8 hours, active metabolite desloratadine 27 hours |
Excretion | 40% as conjugated metabolites into urine Similar amount into the feces |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
Chemical and physical data | |
Formula | C22H23ClN2O2 |
Molar mass | 382.89 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
- ^ "Loratadine Use During Pregnancy". Drugs.com. 10 February 2020. Retrieved 10 April 2020.
- ^ "Claritin Allergy Product information". Health Canada. 25 April 2012. Retrieved 7 June 2022.
- ^ "Clarityn Allergy 10mg Tablets (P & GSL) - Patient Information Leaflet (PIL)". (emc). 30 August 2019. Archived from the original on 10 April 2020. Retrieved 10 April 2020.